Journal of the American Society of Nephrology

Article	Citations
Renal Involvement and Early Prognosis in Patients with COVID-19 Pneumonia	529
AKI in Hospitalized Patients with COVID-19	462
Acute Kidney Injury in COVID-19: Emerging Evidence of a Distinct Pathophysiology	415
Kidney Biopsy Findings in Patients with COVID-19	284
Ultrastructural Evidence for Direct Renal Infection with SARS-CoV-2	268
COVID-19–Associated Kidney Injury: A Case Series of Kidney Biopsy Findings	260
Presentation and Outcomes of Patients with ESKD and COVID-19	254
AKI in Hospitalized Patients with and without COVID-19: A Comparison Study	242
Postmortem Kidney Pathology Findings in Patients with COVID-19	234
AKI and Collapsing Glomerulopathy Associated with COVID-19 and APOL 1 High-Risk Genotype	196
Kidney Outcomes in Long COVID	195
AKI Treated with Renal Replacement Therapy in Critically Ill Patients with COVID-19	194
Clinical Characteristics of and Medical Interventions for COVID-19 in Hemodialysis Patients in Wuhan, China	187
Early Description of Coronavirus 2019 Disease in Kidney Transplant Recipients in New York	163
Epidemiology of COVID-19 in an Urban Dialysis Center	163
A Unifying Approach for GFR Estimation: Recommendations of the NKF-ASN Task Force on Reassessing the Inclusion of Race in Diagnosing Kidney Disease	158
COVID-19 Infection in Kidney Transplant Recipients: Disease Incidence and Clinical Outcomes	156
Dietary Fiber Protects against Diabetic Nephropathy through Short-Chain Fatty Acid–Mediated Activation of G Protein–Coupled Receptors GPR43 and GPR109A	152
Antibody and T Cell Response to SARS-CoV-2 Messenger RNA BNT162b2 Vaccine in Kidney Transplant Recipients and Hemodialysis Patients	149
COVID-19–Associated Glomerular Disease	139
Humoral Response after SARS-CoV-2 mRNA Vaccination in a Cohort of Hemodialysis Patients and Kidney Transplant Recipients	138
Remdesivir in Patients with Acute or Chronic Kidney Disease and COVID-19	137
New ‘Antigens’ in Membranous Nephropathy	136
Phase 3, Randomized, Double-Blind, Active-Comparator (Darbepoetin Alfa) Study of Oral Roxadustat in CKD Patients with Anemia on Hemodialysis in Japan	126
High Prevalence of Asymptomatic COVID-19 Infection in Hemodialysis Patients Detected Using Serologic Screening	121

Histopathologic and Ultrastructural Findings in Postmortem Kidney Biopsy Material in 12 Patients with AKI and COVID-19	120
The Effects of High-Protein Diets on Kidney Health and Longevity	115
Discovery of Autoantibodies Targeting Nephrin in Minimal Change Disease Supports a Novel Autoimmune Etiology	113
Modifiable Lifestyle Factors for Primary Prevention of CKD: A Systematic Review and Meta-Analysis	113
Kidney Single-Cell Atlas Reveals Myeloid Heterogeneity in Progression and Regression of Kidney Disease	111
A Comprehensive Map of mRNAs and Their Isoforms across All 14 Renal Tubule Segments of Mouse	111
Single-Cell Profiling of AKI in a Murine Model Reveals Novel Transcriptional Signatures, Profibrotic Phenotype, and Epithelial-to-Stromal Crosstalk	107
Rituximab or Cyclophosphamide in the Treatment of Membranous Nephropathy: The RI-CYCLO Randomized Trial	103
Incidence, Characteristics, and Outcome of COVID-19 in Adults on Kidney Replacement Therapy: A Regionwide Registry Study	101
Single-Cell Transcriptome Profiling of the Kidney Glomerulus Identifies Key Cell Types and Reactions to Injury	101
Renal, Cardiovascular, and Safety Outcomes of Canagliflozin by Baseline Kidney Function: A Secondary Analysis of the CREDENCE Randomized Trial	101
A Randomized Clinical Trial of Anti–IL-6 Antibody Clazakizumab in Late Antibody-Mediated Kidney Transplant Rejection	100
Roxadustat for Treating Anemia in Patients with CKD Not on Dialysis: Results from a Randomized Phase 3 Study	98
Eplet Mismatch Load and De Novo Occurrence of Donor-Specific Anti-HLA Antibodies, Rejection, and Graft Failure after Kidney Transplantation: An Observational Cohort Study	97
Death after Kidney Transplantation: An Analysis by Era and Time Post-Transplant	92
Soluble Urokinase Receptor (SuPAR) in COVID-19–Related AKI	92
Quantitative Proteomics of All 14 Renal Tubule Segments in Rat	91
Deep Learning–Based Segmentation and Quantification in Experimental Kidney Histopathology	91
Protocadherin 7–Associated Membranous Nephropathy	89
Stopping Renin-Angiotensin System Inhibitors in Patients with Advanced CKD and Risk of Adverse Outcomes: A Nationwide Study	88
Hyperkalemia Risk with Finerenone: Results from the FIDELIO-DKD Trial	88
Effects of Dapagliflozin in Stage 4 Chronic Kidney Disease	87
Kidney and Lung ACE2 Expression after an ACE Inhibitor or an Ang II Receptor Blocker: Implications for COVID-19	86
Safety and Efficacy of Vitamin K Antagonists versus Rivaroxaban in Hemodialysis Patients with Atrial Fibrillation: A Multicenter Randomized Controlled Trial	86
Association of Multiple Plasma Biomarker Concentrations with Progression of Prevalent Diabetic Kidney Disease: Findings from the Chronic Renal Insufficiency Cohort (CRIC) Study	82
Early Change in Albuminuria with Canagliflozin Predicts Kidney and Cardiovascular Outcomes: A Post Hoc Analysis from the CREDENCE Trial	81
Role of Impaired Nutrient and Oxygen Deprivation Signaling and Deficient Autophagic Flux in Diabetic CKD Development: Implications for Understanding the Effects of Sodium-Glucose Cotransporter 2-Inhib	81
Prevalence Estimates of Predicted Pathogenic COL4A3–COL4A5 Variants in a Population Sequencing Database and Their Implications for Alport Syndrome	80
B and T Cell Responses after a Third Dose of SARS-CoV-2 Vaccine in Kidney Transplant Recipients	80
Clinicopathological Features and Outcomes of Acute Kidney Injury in Critically Ill COVID-19 with Prolonged Disease Course: A Retrospective Cohort	79
A Novel Soluble ACE2 Variant with Prolonged Duration of Action Neutralizes SARS-CoV-2 Infection in Human Kidney Organoids	79
Antibody Response to COVID-19 Vaccination in Patients Receiving Dialysis	76
COVID-19 and Calcineurin Inhibitors: Should They Get Left Out in the Storm?	75
Harnessing Expressed Single Nucleotide Variation and Single Cell RNA Sequencing To Define Immune Cell Chimerism in the Rejecting Kidney Transplant	73
Mechanisms and Models of Kidney Tubular Necrosis and Nephron Loss	71
Predictors and Dynamics of the Humoral and Cellular Immune Response to SARS-CoV-2 mRNA Vaccines in Hemodialysis Patients: A Multicenter Observational Study	70
Uremic Toxic Blood-Brain Barrier Disruption Mediated by AhR Activation Leads to Cognitive Impairment during Experimental Renal Dysfunction	69
Exploring the Complexity of Death-Censored Kidney Allograft Failure	68
Short or Long Sleep Duration and CKD: A Mendelian Randomization Study	68
GFR in Healthy Aging: an Individual Participant Data Meta-Analysis of Iohexol Clearance in European Population-Based Cohorts	65
Targeted Single-Cell RNA-seq Identifies Minority Cell Types of Kidney Distal Nephron	65
Urinary Single-Cell Profiling Captures the Cellular Diversity of the Kidney	64
Only Hyperuricemia with Crystalluria, but not Asymptomatic Hyperuricemia, Drives Progression of Chronic Kidney Disease	63
Albuminuria-Lowering Effect of Dapagliflozin, Eplerenone, and Their Combination in Patients with Chronic Kidney Disease: A Randomized Crossover Clinical Trial	62
Spatially Resolved Transcriptomic Analysis of Acute Kidney Injury in a Female Murine Model	60
Serine Protease HTRA1 as a Novel Target Antigen in Primary Membranous Nephropathy	60
Transcriptional Changes in Kidney Allografts with Histology of Antibody-Mediated Rejection without Anti-HLA Donor-Specific Antibodies	58
Urinary Soluble CD163: a Novel Noninvasive Biomarker of Activity for Lupus Nephritis	58
Reassessing the Inclusion of Race in Diagnosing Kidney Diseases: An Interim Report from the NKF-ASN Task Force	57
Long-Term Exposure to Ambient PM2.5 and Increased Risk of CKD Prevalence in China	55

Intravenous Iron Dosing and Infection Risk in Patients on Hemodialysis: A Prespecified Secondary Analysis of the PIVOTAL Trial	55
In Patients with Membranous Lupus Nephritis, Exostosin-Positivity and Exostosin-Negativity Represent Two Different Phenotypes	55
The Relationship between AKI and CKD in Patients with Type 2 Diabetes: An Observational Cohort Study	55
The Trifecta Study: Comparing Plasma Levels of Donor-derived Cell-Free DNA with the Molecular Phenotype of Kidney Transplant Biopsies	54
Missing Self-Induced Activation of NK Cells Combines with Non-Complement-Fixing Donor-Specific Antibodies to Accelerate Kidney Transplant Loss in Chronic Antibody-Mediated Rejection	52
Roxadustat Versus Epoetin Alfa for Treating Anemia in Patients with Chronic Kidney Disease on Dialysis: Results from the Randomized Phase 3 ROCKIES Study	52
Comparing Approaches to Normalize, Quantify, and Characterize Urinary Extracellular Vesicles	52
Multicenter Study to Transplant Hepatitis C–Infected Kidneys (MYTHIC): An Open-Label Study of Combined Glecaprevir and Pibrentasvir to Treat Recipients of Transplanted Kidneys from Deceased Donors wit	52
Immunogenicity of SARS-CoV-2 Vaccine in Dialysis	51
Caution in Identifying Coronaviruses by Electron Microscopy	51
A Randomized Trial on the Effect of Phosphate Reduction on Vascular End Points in CKD (IMPROVE-CKD)	51
Fructose Production and Metabolism in the Kidney	50
Endogenous miR-204 Protects the Kidney against Chronic Injury in Hypertension and Diabetes	50
Management of Obesity in Adults with CKD	49
Automated Computational Detection of Interstitial Fibrosis, Tubular Atrophy, and Glomerulosclerosis	49
Kinetics of Anti–SARS-CoV-2 IgG Antibodies in Hemodialysis Patients Six Months after Infection	48
Kim-1 Targeted Extracellular Vesicles: A New Therapeutic Platform for RNAi to Treat AKI	48
Hnf4a Is Required for the Development of Cdh6-Expressing Progenitors into Proximal Tubules in the Mouse Kidney	48
Gut Microbial Metabolites Induce Donor-Specific Tolerance of Kidney Allografts through Induction of T Regulatory Cells by Short-Chain Fatty Acids	47
Hematopoietic Stem Cell Transplant-Membranous Nephropathy Is Associated with Protocadherin FAT1	47
Association of Clonal Hematopoiesis of Indeterminate Potential with Worse Kidney Function and Anemia in Two Cohorts of Patients with Advanced Chronic Kidney Disease	47
Empagliflozin Inhibits Proximal Tubule NHE3 Activity, Preserves GFR, and Restores Euvolemia in Nondiabetic Rats with Induced Heart Failure	47
Efficacy of Rituximab and Plasma Exchange in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis with Severe Kidney Disease	47
PKD1-Dependent Renal Cystogenesis in Human Induced Pluripotent Stem Cell-Derived Ureteric Bud/Collecting Duct Organoids	47
Major Variation across Local Transplant Centers in Probability of Kidney Transplant for Wait-Listed Patients	46
Pre-emptive Short-term Nicotinamide Mononucleotide Treatment in a Mouse Model of Diabetic Nephropathy	46
SARS-CoV-2 Vaccine Acceptability in Patients on Hemodialysis: A Nationwide Survey	45
Initial Effects of COVID-19 on Patients with ESKD	45
Real-World Effectiveness and Immunogenicity of BNT162b2 and mRNA-1273 SARS-CoV-2 Vaccines in Patients on Hemodialysis	44
Defects in KCNJ16 Cause a Novel Tubulopathy with Hypokalemia, Salt Wasting, Disturbed Acid-Base Homeostasis, and Sensorineural Deafness	44
Discovery and Validation of a Urinary Exosome mRNA Signature for the Diagnosis of Human Kidney Transplant Rejection	44
A Randomized Trial of Tenapanor and Phosphate Binders as a Dual-Mechanism Treatment for Hyperphosphatemia in Patients on Maintenance Dialysis (AMPLIFY)	44
Kidney Failure Prediction Models: A Comprehensive External Validation Study in Patients with Advanced CKD	43
Vitamin K Supplementation to Improve Vascular Stiffness in CKD: The K4Kidneys Randomized Controlled Trial	43
Acute Start Peritoneal Dialysis during the COVID-19 Pandemic: Outcomes and Experiences	43
Gentamicin-Induced Acute Kidney Injury in an Animal Model Involves Programmed Necrosis of the Collecting Duct	43
Progressive Cellular Senescence Mediates Renal Dysfunction in Ischemic Nephropathy	43
Perturbations of the Gut Microbiome and Metabolome in Children with Calcium Oxalate Kidney Stone Disease	43
Does SARS-CoV-2 Infect the Kidney?	42
Kidney Disease-Associated APOL1 Variants Have Dose-Dependent, Dominant Toxic Gain-of-Function	42
Identification of an Altered Matrix Signature in Kidney Aging and Disease	42
Failure to Advance Access to Kidney Transplantation over Two Decades in the United States	41
Optimal Phosphate Control Related to Coronary Artery Calcification in Dialysis Patients	41
Ziltivekimab for Treatment of Anemia of Inflammation in Patients on Hemodialysis: Results from a Phase 1/2 Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial	41
Subtyping CKD Patients by Consensus Clustering: The Chronic Renal Insufficiency Cohort (CRIC) Study	41
Deletion of Myeloid Interferon Regulatory Factor 4 (Irf4) in Mouse Model Protects against Kidney Fibrosis after Ischemic Injury by Decreased Macrophage Recruitment and Activation	41
Assessment of the Utility of Kidney Histology as a Basis for Discarding Organs in the United States: A Comparison of International Transplant Practices and Outcomes	40
In Vivo Assessment of Size-Selective Glomerular Sieving in Transplanted Human Induced Pluripotent Stem Cell–Derived Kidney Organoids	40
Increasing Peritoneal Dialysis Use in Response to the COVID-19 Pandemic: Will It Go Viral?	40
Conversion from Calcineurin Inhibitor– to Belatacept-Based Maintenance Immunosuppression in Renal Transplant Recipients: A Randomized Phase 3b Trial	40
Conventional and Genetic Evidence on the Association between Adiposity and CKD	39
Proteomic Analysis Identifies Distinct Glomerular Extracellular Matrix in Collapsing Focal Segmental Glomerulosclerosis	38
Genome-Wide Meta-Analysis Identifies Three Novel Susceptibility Loci and Reveals Ethnic Heterogeneity of Genetic Susceptibility for IgA Nephropathy	38
Single-Nucleus RNA Sequencing Identifies New Classes of Proximal Tubular Epithelial Cells in Kidney Fibrosis	38
Changes in NAD and Lipid Metabolism Drive Acidosis-Induced Acute Kidney Injury	38
Missing Self–Induced Microvascular Rejection of Kidney Allografts: A Population-Based Study	38
ADCK4 Deficiency Destabilizes the Coenzyme Q Complex, Which Is Rescued by 2,4-Dihydroxybenzoic Acid Treatment	38
Early Predictors of Arteriovenous Fistula Maturation: A Novel Perspective on an Enduring Problem	38
Serum Biomarkers of Iron Stores Are Associated with Increased Risk of All-Cause Mortality and Cardiovascular Events in Nondialysis CKD Patients, with or without Anemia	38
Renal AAV2-Mediated Overexpression of Long Non-Coding RNA H19 Attenuates Ischemic Acute Kidney Injury Through Sponging of microRNA-30a-5p	37
Potential Therapeutic Targets for Cisplatin-Induced Kidney Injury: Lessons from Other Models of AKI and Fibrosis	37
COVID-19 Infection in ESKD: Findings from a Prospective Disease Surveillance Program at Dialysis Facilities in New York City and Long Island	36
Phase 3 Randomized Study Comparing Vadadustat with Darbepoetin Alfa for Anemia in Japanese Patients with Nondialysis-Dependent CKD	35
Hemodialysis with Cohort Isolation to Prevent Secondary Transmission during a COVID-19 Outbreak in Korea	35
Inflammatory Bowel Disease Is More Common in Patients with IgA Nephropathy and Predicts Progression of ESKD: A Swedish Population-Based Cohort Study	35
The Impact of Vaccination on Incidence and Outcomes of SARS-CoV-2 Infection in Patients with Kidney Failure in Scotland	35
COVID-19 Vaccine Type and Humoral Immune Response in Patients Receiving Dialysis	35
Secondary Immunodeficiency Related to Kidney Disease (SIDKD)—Definition, Unmet Need, and Mechanisms	35
Prognostic Significance of Ambulatory BP Monitoring in CKD: A Report from the Chronic Renal Insufficiency Cohort (CRIC) Study	34
Transcriptomes of Major Proximal Tubule Cell Culture Models	34
Impaired Renal HCO3 - Excretion in Cystic Fibrosis	34
Tubule-Specific Mst1/2 Deficiency Induces CKD via YAP and Non-YAP Mechanisms	33
Apolipoprotein L1-Specific Antibodies Detect Endogenous APOL1 inside the Endoplasmic Reticulum and on the Plasma Membrane of Podocytes	33
Vaccine Effectiveness Against SARS-CoV-2 Infection and Severe Outcomes in the Maintenance Dialysis Population in Ontario, Canada	33
Early Detection of CKD: Implications for Low-Income, Middle-Income, and High-Income Countries	33
Complement C3a and C3a Receptor Activation Mediates Podocyte Injuries in the Mechanism of Primary Membranous Nephropathy	33
The Immunocompromised Transplant Recipient and SARS-CoV-2 Infection	33
Health Care Costs by Type of Expenditure across eGFR Stages among Patients with and without Diabetes, Cardiovascular Disease, and Heart Failure	33
Detection of SARS-CoV-2 Antibodies in Kidney Transplant Recipients	33
Synaptopodin Is Dispensable for Normal Podocyte Homeostasis but Is Protective in the Context of Acute Podocyte Injury	33

Rate and Predictors of Finding Monoclonal Gammopathy of Renal Significance (MGRS) Lesions on Kidney Biopsy in Patients with Monoclonal Gammopathy	33
O- and N-Glycosylation of Serum Immunoglobulin A is Associated with IgA Nephropathy and Glomerular Function	33
Mendelian Randomization Analysis as a Tool to Gain Insights into Causes of Diseases: A Primer	33
Ferroptosis Promotes Cyst Growth in Autosomal Dominant Polycystic Kidney Disease Mouse Models	33
Twice-Weekly Hemodialysis Is an Option for Many Patients in Times of Dialysis Unit Stress	32
A Time-Updated, Parsimonious Model to Predict AKI in Hospitalized Children	32
Long-Term Efficacy and Safety of Repeated Rituximab to Maintain Remission in Idiopathic Childhood Nephrotic Syndrome: An International Study	32
Longitudinal Outcomes of COVID-19–Associated Collapsing Glomerulopathy and Other Podocytopathies	32
Effects of Short-Term Potassium Chloride Supplementation in Patients with CKD	32
Safety and Efficacy of Daratumumab in Patients with Proliferative GN with Monoclonal Immunoglobulin Deposits	32
Intestinal Bacterial Translocation Contributes to Diabetic Kidney Disease	32
Measuring Patient Activation as Part of Kidney Disease Policy: Are We There Yet?	32
Disaster Response to the COVID-19 Pandemic for Patients with Kidney Disease in New York City	31
Quantifying Duration of Proteinuria Remission and Association with Clinical Outcome in IgA Nephropathy	31
Striking a Balance in Simultaneous Heart Kidney Transplant: Optimizing Outcomes for All Wait-Listed Patients	31
Large-Scale Proteomic Assessment of Urinary Extracellular Vesicles Highlights Their Reliability in Reflecting Protein Changes in the Kidney	31
Interventions To Attenuate Vascular Calcification Progression in Chronic Kidney Disease: A Systematic Review of Clinical Trials	31
Protein Kinase C-δ Mediates Kidney Tubular Injury in Cold Storage–Associated Kidney Transplantation	31
Sex Differences in Age-Related Loss of Kidney Function	30
Human or Chimeric Monoclonal Anti-CD20 Antibodies for Children with Nephrotic Syndrome: A Superiority Randomized Trial	30
Multifunctional Natural Polymer Nanoparticles as Antifibrotic Gene Carriers for CKD Therapy	30
Extracellular Matrix Injury of Kidney Allografts in Antibody-Mediated Rejection: A Proteomics Study	30
Larger Nephron Size and Nephrosclerosis Predict Progressive CKD and Mortality after Radical Nephrectomy for Tumor and Independent of Kidney Function	30
Coordinated Circulating T Follicular Helper and Activated B Cell Responses Underlie the Onset of Antibody-Mediated Rejection in Kidney Transplantation	30
The Exclusion of Patients with CKD in Prospectively Registered Interventional Trials for COVID-19—a Rapid Review of International Registry Data	29
National Estimates of CKD Prevalence and Potential Impact of Estimating Glomerular Filtration Rate Without Race	29
Kidney Function after Treatment for Childhood Cancer: A Report from the St. Jude Lifetime Cohort Study	29
The FDA Metformin Label Change and Racial and Sex Disparities in Metformin Prescription among Patients with CKD	29
Lineage Tracing and Single-Nucleus Multiomics Reveal Novel Features of Adaptive and Maladaptive Repair after Acute Kidney Injury	29
Advance Care Planning in Older Adults with CKD: Patient, Care Partner, and Clinician Perspectives	29
Podocyte Aging: Why and How Getting Old Matters	28
High SARS-CoV-2 Viral Load in Urine Sediment Correlates with Acute Kidney Injury and Poor COVID-19 Outcome	28
A Population-Based Analysis of the Risk of Glomerular Disease Relapse after COVID-19 Vaccination	28
Data-driven Derivation and Validation of Novel Phenotypes for Acute Kidney Transplant Rejection using Semi-supervised Clustering	28
Intensity of Macrophage Infiltration in Glomeruli Predicts Response to Immunosuppressive Therapy in Patients with IgA Nephropathy	27
Expansion of Escherichia-Shigella in Gut Is Associated with the Onset and Response to Immunosuppressive Therapy of IgA Nephropathy	27
Donor-Specific Antibody Is Associated with Increased Expression of Rejection Transcripts in Renal Transplant Biopsies Classified as No Rejection	27
Crucial Role of AIM/CD5L in the Development of Glomerular Inflammation in IgA Nephropathy	27
Netrin G1 Is a Novel Target Antigen in Primary Membranous Nephropathy	27
Galactose-Deficient IgA1 B cells in the Circulation of IgA Nephropathy Patients Carry Preferentially Lambda Light Chains and Mucosal Homing Receptors	27
Spatiotemporal ATP Dynamics during AKI Predict Renal Prognosis	27
SARS-CoV-2 Vaccines in Kidney Transplant Recipients: Will They Be Safe and Effective and How Will We Know?	27
Epithelial Vasopressin Type-2 Receptors Regulate Myofibroblasts by a YAP-CCN2–Dependent Mechanism in Polycystic Kidney Disease	26
COVID-19, Racism, and Racial Disparities in Kidney Disease: Galvanizing the Kidney Community Response	26
Polygenic Risk Scores for Kidney Function and Their Associations with Circulating Proteome, and Incident Kidney Diseases	26
Racial Disparities in Eligibility for Preemptive Waitlisting for Kidney Transplantation and Modification of eGFR Thresholds to Equalize Waitlist Time	26
Tissue Culture Models of AKI: From Tubule Cells to Human Kidney Organoids	26
Gitelman-Like Syndrome Caused by Pathogenic Variants in mtDNA	26
Mortality in US Hemodialysis Patients Following Exposure to Wildfire Smoke	26
Primary Nephrotic Syndrome and Risks of ESKD, Cardiovascular Events, and Death: The Kaiser Permanente Nephrotic Syndrome Study	25
Cyclin-Dependent Kinase 1 Activity Is a Driver of Cyst Growth in Polycystic Kidney Disease	25
mTOR-Activating Mutations in RRAGD Are Causative for Kidney Tubulopathy and Cardiomyopathy	25
Mycophenolate Mofetil after Rituximab for Childhood-Onset Complicated Frequently-Relapsing or Steroid-Dependent Nephrotic Syndrome	25
Platelet Function in CKD: A Systematic Review and Meta-Analysis	25
Effect of a 3-Year Lifestyle Intervention in Patients with Chronic Kidney Disease: A Randomized Clinical Trial	25
Molecular Mechanisms of Renal Magnesium Reabsorption	25
Sphingosine-1-Phosphate Metabolism and Signaling in Kidney Diseases	24
A Novel Soluble ACE2 Protein Provides Lung and Kidney Protection in Mice Susceptible to Lethal SARS-CoV-2 Infection	24
Sex Differences in the Recognition, Monitoring, and Management of CKD in Health Care: An Observational Cohort Study	24
Reappraisal of Renal Arteritis in ANCA-associated Vasculitis: Clinical Characteristics, Pathology, and Outcome	24
Kidney Disease, Intensive Hypertension Treatment, and Risk for Dementia and Mild Cognitive Impairment: The Systolic Blood Pressure Intervention Trial	24
Kidney Histopathology Can Predict Kidney Function in ANCA-Associated Vasculitides with Acute Kidney Injury Treated with Plasma Exchanges	24
Advanced Tertiary Lymphoid Tissues in Protocol Biopsies are Associated with Progressive Graft Dysfunction in Kidney Transplant Recipients	24
A Neutralizing IL-11 Antibody Improves Renal Function and Increases Lifespan in a Mouse Model of Alport Syndrome	24
Improving Care for Patients after Hospitalization with AKI	24
Kidney-Targeted Renalase Agonist Prevents Cisplatin-Induced Chronic Kidney Disease by Inhibiting Regulated Necrosis and Inflammation	24
Endopeptidase Cleavage of Anti-Glomerular Basement Membrane Antibodies in vivo in Severe Kidney Disease: An Open-Label Phase 2a Study	24
LIM-Nebulette Reinforces Podocyte Structural Integrity by Linking Actin and Vimentin Filaments	24
Acquired Decline in Ultrafiltration in Peritoneal Dialysis: The Role of Glucose	24
Treatment Effect of the SGLT2 Inhibitor Empagliflozin on Chronic Syndrome of Inappropriate Antidiuresis: Results of a Randomized, Double-Blind, Placebo-Controlled, Crossover Trial	24
Integration of GWAS Summary Statistics and Gene Expression Reveals Target Cell Types Underlying Kidney Function Traits	24
Epidemiology and Outcomes of COVID-19 in Home Dialysis Patients Compared with In-Center Dialysis Patients	24
Long-Term Kidney Outcomes Following Dialysis-Treated Childhood Acute Kidney Injury: A Population-Based Cohort Study	24
Systematic Review and Meta-Analysis of Plasma and Urine Biomarkers for CKD Outcomes	23
Decreased Renal Gluconeogenesis Is a Hallmark of Chronic Kidney Disease	23
Proteins Associated with Risk of Kidney Function Decline in the General Population	23
High Oxalate Concentrations Correlate with Increased Risk for Sudden Cardiac Death in Dialysis Patients	23
Activation of Stimulator of IFN Genes (STING) Causes Proteinuria and Contributes to Glomerular Diseases	23
Current Methodological Challenges of Single-Cell and Single-Nucleus RNA-Sequencing in Glomerular Diseases	23
Early Postoperative Basal Insulin Therapy versus Standard of Care for the Prevention of Diabetes Mellitus after Kidney Transplantation: A Multicenter Randomized Trial	23
Human Kidney Spheroids and Monolayers Provide Insights into SARS-CoV-2 Renal Interactions	23
Beyond a Passive Conduit: Implications of Lymphatic Biology for Kidney Diseases	23
mTOR Inhibitors Prevent CMV Infection through the Restoration of Functional αβ and γδ T cells in Kidney Transplantation	23
Banff Human Organ Transplant Transcripts Correlate with Renal Allograft Pathology and Outcome: Importance of Capillaritis and Subpathologic Rejection	22
Sex-specific Associations of Sex Hormone Binding Globulin with CKD and Kidney Function: A Univariable and Multivariable Mendelian Randomization Study in the UK Biobank	22
Lipocalin-2 Exacerbates Lupus Nephritis by Promoting Th1 Cell Differentiation	22
Antibody Status, Disease History, and Incidence of SARS-CoV-2 Infection Among Patients on Chronic Dialysis	22
Cilastatin Ameliorates Rhabdomyolysis-induced AKI in Mice	22
Accuracy of GFR Estimating Equations in Patients with Discordances between Creatinine and Cystatin C-Based Estimations	21
How to Get Started with Single Cell RNA Sequencing Data Analysis	21
Expanded Imaging Classification of Autosomal Dominant Polycystic Kidney Disease	21
The Mineralocorticoid Receptor in Salt-Sensitive Hypertension and Renal Injury	21
A Higher Foci Density of Interstitial Fibrosis and Tubular Atrophy Predicts Progressive CKD after a Radical Nephrectomy for Tumor	21
Interaction between Epithelial Sodium Channel γ-Subunit and Claudin-8 Modulates Paracellular Sodium Permeability in Renal Collecting Duct	20
Glomerular Endothelial Cell-Derived microRNA-192 Regulates Nephronectin Expression in Idiopathic Membranous Glomerulonephritis	20